Last updated: Nov 20, 2026, 12:00 AM

Halozyme Therapeutics Inc Exchange (NASDAQ, USD)

HALO

95.80
-0.17 (-0.18%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
35.77%
3 year return (CAGR)
36.70%
5 year return (CAGR)
20.20%
10 year return (CAGR)
25.79%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
10.87B
Price/Sales
6.54
Ent value
13.14B
Price/Book
75.75
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
26.29
PEG
-
Forward P/E
8.96
EPS growth
22.89%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open95.29
Daily high97.96
Daily low95.01
Daily Volume1.61M
All-time high131.18
1y analyst estimate108.89
Beta0.90
EPS (TTM)3.41
Dividend per share0.00
Ex-div date-
Next earnings date24 Feb 2026

Ready to capitalize on Halozyme Therapeutics Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
HALOS&P500
Current price drop from All-time high-26.97%-6.28%
Highest price drop-74.26%-56.47%
Date of highest drop4 Dec 20089 Mar 2009
Avg drop from high-31.36%-10.64%
Avg time to new high33 days12 days
Max time to new high1209 days1805 days